Physician profile

Charles Penvose

Foot & Ankle Surgery · Newark, OH

NPI 1144853649

$34,434.53

in general payments reported to CMS, 2019-2025

29 companies · $1,051 in 2025

The $1,051 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

See the full distribution for Foot & Ankle Surgery

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$4,035.91
Travel and Lodging$2,221.19
Education$245.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Arthrex, INC. $13,797.27 2021-2022
Stryker Corporation $7,292.42 2021-2025 Prophecy, Hoffmann, Variax
Vilex LLC $2,773.95 2022
Acumed LLC $2,434.14 2021-2023 Acumed, Osteomed
Cdc Medical LLC $1,458.50 2022-2023
International Life Sciences $1,297.10 2023
Paragon 28, INC. $1,295.25 2021-2024 Phantom Hindfoot, Mtp
Medline Industries LP $1,222.73 2021
United Orthopedics LLC $1,200.00 2021
Mid-Atlantic Surgical Systems, LLC $318.87 2025
Smith+Nephew, INC. $167.84 2023-2025 Stravix Pl, Stravix, Grafix Pl
Linvatec Corporation $146.26 2022
Sanara Medtech INC. $146.16 2025 Celleraterx
Kerecis Limited $139.70 2023 Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide
Flower Orthopedics Coporation $136.53 2022
Show all 29 companies
CompanyGeneral paymentsYearsTop products
Orthofix Medical, INC. $129.63 2023 Truelok System, Tl-Hex Truelok Hexapod System
Treace Medical Concepts, INC. $105.63 2024-2025
Averitas Pharma INC. $94.68 2023-2025 Qutenza
Paratek Pharmaceuticals, INC. $93.91 2022-2024 Nuzyra
Organogenesis INC. $28.69 2022-2024
Vertex Pharmaceuticals Incorporated $20.94 2025
Trice Medical, INC. $20.43 2024
Nevro Corp. $19.86 2023 Senza
Depuy Synthes Sales INC. $19.04 2025 Motoband, Motoband Cp
Bioventus LLC $18.95 2025 Exogen Ultrasound Bone Healing System
Dynasplint Systems INC. $18.89 2023 Dynasplint
Ortho Dermatologics, A Division of Bausch Health US, LLC $16.10 2023 Jublia
Horizon Therapeutics Plc $15.72 2023 Krystexxa
Microaire Surgical Instruments LLC $5.34 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Charles Penvose

$34,434.53

in general payments reported 2019-2025

Years
2021-2025
Top company
Arthrex, INC.
Context
The $1,051 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).

https://glasscript.com/doctor/8087333/charles-penvose

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.